Immunochemical staining of human post-mortem brain sections from patients with MS demonstrated expression of H3R in Nogo-A-positive oligodendrocytes in the center of different types of MS lesions (active/chronic active, shadow and grey matter lesions [GM]) (Fig 4A). Here, HRH3 is linked to myeloid sarcoma.